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Summary
Background: During periods of human expansion into
new environments, recognition of bitter natural toxins
through taste may have conferred an important selective
advantage. The G protein-coupled receptor encoded by
TAS2R16 mediates response to salicin, amygdalin, and
many bitter β-glucopyranosides. β-glucopyranosides
are ubiquitous in nature, with many having a highly
toxic cyanogenic activity.
Results: We examined evidence for natural selection
on the human receptor TAS2R16 by sequencing the en-
tire coding region, as well as part of the 5# and 3# UTRs,
in 997 individuals from 60 human populations. We de-
tected signatures of positive selection, indicated by an
excess of evolutionarily derived alleles at the nonsyn-
onymous site K172N and two linked sites and signifi-
cant values of Fay and Wu’s H statistics in 19 popula-
tions. The estimated age range for the common
ancestor of the derived N172 variant is 78,700–791,000
years, placing it in the Middle Pleistocene and before
the expansion of early humans out of Africa. Using cal-
cium imaging in cells expressing different receptor vari-
ants, we showed that N172 is associated with an in-
creased sensitivity to salicin, arbutin, and five different
cyanogenic glycosides.
Conclusion: We have detected a clear signal of positive
selection at the bitter-taste receptor gene TAS2R16. We
speculate that the increased sensitivity that is shown
toward harmful cyanogenic glycosides and conferred*Correspondence: n.soranzo@ucl.ac.uk
5 Present address: Public Health Sciences, University of Edinburgh,
Teviot Place, Edinburgh, EH8 9AG Scotland.
6 Present address: Center for Population Genomics and Pharmaco-
genetics, Duke Institute for Genomic Sciences and Policy, Duke
University, DUMC Box 3471, 4006 GSRB II, 103 Research Drive,
Durham, North Carolina.by the N172 allele may have driven the signal of selec-
tion at an early stage of human evolution.
Introduction
The chemical senses of taste and smell control our in-
teraction with the chemical environment and influence
our food preference [1]. Among the five different taste
modalities recognized by humans—bitter, sweet, sour,
umami (monosodium glutamate), and salty—bitter taste
plays an important protective role because many plant
toxins have a bitter taste [1]. The ability to recognize
harmful compounds through taste may therefore influ-
ence survival, at least in certain environments [2]. Hu-
mans can detect bitter compounds at very low concen-
trations and show averse reactions toward foods that
are considered as excessively bitter [1].
The initiation of bitter-taste signaling is mediated by
a highly variable family of seven-transmembrane G pro-
tein-coupled receptor genes (TAS2Rs or T2Rs), com-
prising 25 putatively functional genes and eight pseu-
dogenes in humans [3–5]. TAS2R receptors are
encoded by small intronless genes that are 876–1020
bp [6] and are selectively expressed in taste receptor
cells of the tongue and palate epithelium [3]. Several
TAS2R receptors having different substrate specificities
are generally coexpressed within the same taste cells
[4]. This coexpression may explain why structurally un-
related compounds are often perceived by humans as
having a uniformly bitter taste [4].
Mammals display considerable variation in their
TAS2R gene repertoires [5, 7]. The evolution of the fam-
ily along the mouse-human lineage took place through
gene duplication and adaptive diversification [5, 7]. In
higher primates, comparative analyses of TAS2R genes
have demonstrated overall hallmarks of neutral evolu-
tion, with ongoing pseudogenization and loss of selec-
tive constraints [5, 6]. However, there are some excep-
tions to this overall trend. High levels of variability in
the intercellular and C-terminal domains mediating
substrate specificity and downstream signaling are
thought to ensure a wide spectrum of phenotypic re-
sponse [5, 7, 8]. Segregation of different functional al-
leles in TAS2R receptors has been shown to contribute
to variability in bitter-taste response in both humans
and mice [4, 9, 10]. One previous study documents nat-
ural selection acting on functional TAS2R38 alleles [11].
Diversification of TAS2R functions during phyloge-
netic evolution is thought to reflect, at least in part,
adaptation to changing nutritional environments. The
known substrates of TAS2R receptors include structur-
ally different compounds [9, 10, 12–15], some of which
are potent natural toxins [12, 14]. The overall loss of
evolutionary constraints in chimpanzees and in humans
[6] may be linked to the introduction of new diet and
lifestyle practices that reduced the importance of bitter-
taste recognition as a means of toxin avoidance; for
instance, such practices include the use of cooking to
inactivate toxins or increased meat and fruit dietary in-
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smediating recognition of particularly harmful and ubiq-
uitous compounds may have been under stronger se- a
nlective pressures, at least in some stages of human
evolution. c
aThe TAS2R16 receptor is encoded by TAS2R16 (Hugo
Approved Gene Symbol [18], also known as hT2R16 l
p[3]). TAS2R16 mediates recognition of β-glucopyrano-
sides [12], a class of compounds ubiquitous in nature s
[19], including some with a highly toxic cyanogenic ac-
tivity [1]. We investigated natural selection by rese- t
Hquencing the gene in a worldwide sample of 60 human
populations. We detected evidence of positive selec- c
ntion at TAS2R16, likely acting on the high-sensitivity al-
lele N172. Overall, our data suggest that the improved c
asensitivity toward β-glucopyranosides has been advan-




KPatterns of TAS2R16 Diversity
in Human Populations b
TWe sequenced the entire coding sequence of TAS2R16
(876 bp) and 203 bp of noncoding 5# and 3# UTR se- c
nquence in 997 individuals from a global sample. The
population sample includes 52 populations of the hu-
man diversity panel [20] and eight additional popula- S
Ttions chosen to cover geographic regions poorly repre-
sented in the human diversity panel (see Table S1 in the a
iSupplemental Data available with this article online).
We found 17 polymorphic sites in humans (Table 1), l
aall contained within the terminal two-thirds of the gene-
coding sequence (π = 6.1 × 10−4, q = 1.9 × 10−3). For t
lthese loci, we defined evolutionarily ancestral alleles by
comparison with the homologous primate sequences; T
cwe defined evolutionarily derived alleles as the alterna-
tive alleles at these loci, or as the alleles newly arisen b
Win humans. Out of the 17 polymorphic loci, six had
moderately high frequencies at least in Africa (un-Table 1. Summary of TAS2R16 Polymorphisms
Mean Frequency of Ancestral
Allele (%)
dbSNP IDa Nucleotide Change Amino Acid Change Ancestral Allele African Non-African FSTb
rs2233988 C300T T100T C 85.6 99.1 0.4
ss32475769 G301A V101M G 100 w100 w0
rs2692396 C303G V101V C 13.7 0.8 0.38
ss32475771 C321G S108S C 97.1 w100 0.08
ss32475772 C333T T111T C w100 100 w0
ss32475773 A340G I114V A 96.8 w100 0.08
ss32475774 T347C L116P T 100 w100 w0
rs2233989 T460C L154L T 93 99.7 0.24
ss32475776 C481T P161S C 98.4 100 0.11
rs846664 G516T K172N G 15.6 0.9 0.45
ss32475778 A530C Q177P A 100 w100 w0
ss32475779 A646G N216D A 100 w100 w0
ss32475780 C662T A221V C 97.3 100 0.06
rs860170 A665G H222R A 96.4 69 0.21
ss32475782 G703A V235M G 98.8 100 w0
ss32475783 T718G F240V T 100 w100 w0
rs1204014 A846G T282T A 13.1 1.6 0.29
a rs dbSNP IDs indicate the six common alleles, and ss IDs indicate dbSNP accession numbers for variants discovered in this study.
b Values calculated for the 52 populations of the HDP only are given.erlined in Table 1; Table S1); the remaining 11 were
ingletons or rare. Among the six high-frequency vari-
nts, four were synonymous changes and two were
onsynonymous changes. These two nonsynonymous
hanges are particularly important, because they may
ffect receptor function. The first, G516T (rs846664),
eads to a Lys-Asn substitution at position 172 of the
rotein (K172N). A665G (rs860170) causes a His-Arg
ubstitution at amino acid 222 (H222R).
The polymorphic sites define four common haplo-
ypes (Table 2 and Figure 1A). Two main haplotypes,
AP-A (N172/H222) and HAP-B (N172/R222), are both
haracterized by evolutionarily derived alleles at the
onsynonymous site K172N (N172). In addition, HAP-A
arries the ancestral A allele at the site H222R (H222),
nd HAP-B carries the derived G allele (R222). HAP-A
nd HAP-B are very frequent throughout the world and
ointly account for 77.6% of all African and 98% of non-
frican haplotypes (Table 2). HAP-C (K172/H222) and
AP-D (K172/H222) are defined by ancestral states at
172N and H222R, and they are further differentiated
y a synonymous substitution at locus T460C (L154L).
he two ancestral haplotypes HAP-C and HAP-D ac-
ount jointly for 13.8% of all African and only 0.5% of
on-African chromosomes.
ignatures of Positive Selection at TAS2R16
he geographic distribution of TAS2R16 variants is
typical of the majority of human alleles. Under neutral-
ty, evolutionarily derived variants will generally display
ower frequencies in populations than ancestral vari-
nts do. A positive selection event, however, may act
o rapidly increase the frequency of an allele and the
inked sites through the process of hitch-hiking [21].
he resulting decrease in linked variation represents a
haracteristic signature of positive selection and can
e detected with appropriate tests such as Fay and
u’s H statistic [22].
We found that the three sites C303G (V101V), G516T
Positive Selection on TAS2R16
1259Table 2. Summary of TAS2R16 Haplotypes
Number of Chromosomes and Frequency (%, in Brackets)cAmino Acid
at K172N/ Central/ Middle
Haplotype H222R Functional Effect Africa America South Asia East Asia Europe East Oceania
HAP-C/D KHa low sensitivity 34 (13.8) — 1 (0.2) — — 7 (2.4) —
HAP-A NH high sensitivity 188 (76.4) 154 (80.2) 272 (66.7) 275 (58.5) 158 (65.8) 202 (70.1) 133 (88.7)
HAP-B NR high sensitivity 3 (1.2) 36 (18.8) 126 (30.9) 193 (41.1) 74 (30.8) 75 (26) 16 (10.7)
Otherb 21 (8.5) 2 (1) 7 (1.7) 2 (0.4) 8 (3.3) 4 (1.4) 1 (0.7)
Total 246 192 408 470 240 288 150
a Ancestral state.
b Haplotypes containing rarer/singleton variants and not tested in the functional analysis.
c Regions defined in Table S1.hypothesis of positive selection acting on TAS2R16.pothesis, we applied Fay and Wu’s test of selection on
Figure 1. TAS2R16 Allele and Haplotype Fre-
quency Distribution in the Worldwide
Sample
(A) Haplotype network for the four common
haplotypes; the size of each pie chart is pro-
portional to the total number of haplotypes;
pie segments indicate main continents.
(B and C) Worldwide frequency distribution
of the two ancestral variants K172 (B) and
H222 (C) are shown.(K172N), and A846G (T282T) had very high derived-
allele frequencies (Table 1), a pattern compatible with
positive selection acting on this gene. To test this hy-the TAS2R16 sequence data. We obtained highly signif-
icant negative values of Fay and Wu’s H statistics in 19
populations (Table S2), a deviation consistent with the
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Bantu, and Yoruba) had borderline significant H values l
(0.05% p-value% 0.1); these populations had relatively s
high ancestral-allele frequencies at these three sites in m
comparison to all the other populations. In all the re-
maining populations, Fay and Wu’s test was not signifi- A
cant, as a result of the fact that the derived alleles at W
N172 and the two other linked variants were completely c
fixed (Table S2). These populations therefore also con- Y
form to the hypothesis of a global selective event and [
exhibit an even more extreme genetic pattern than the 9
populations with significant H values. 3
The excess of linked derived alleles is the principal y
indicator of selection here. We did not detect signifi- g
cant evidence for selection with other tests of selection e
based on the allelic spectrum; these tests included t
both tests sensitive to ancestral states (Fu and Li’s F i
and D) and tests that are not sensitive to ancestral p
states (Tajima’s D, Fu and Li’s F* and D*) (Table S2). r
Failure to detect natural selection here is not alarming d
because these latter tests of selection are expected to
be less sensitive than Fay and Wu’s H, particularly F
those not drawing on information about ancestral states. a
TAS2R16 appears to differ from the majority of hu- K
man loci with respect also to population differentiation t
and extended linkage disequilibrium [23]. We estimated m
the value, FST, of the population-differentiation statis- g
tics for the 17 TAS2R16 sites in a subset of the data w
corresponding to the 52 populations of the human di- c
versity panel (Table 1). K172N had the highest FST value A
among all TAS2R16 sites (0.45). We then compared the
a
FST at K172N to an empirical FST distribution of 210 v
short indels typed in the same sample. We found that
i
only 11 out of 210 indels had an FST higher than that of m
K172N, corresponding to an empirical p-value of 0.057
a
(=12/211). All the other TAS2R16 variants had lower FST cvalues (0.21–0.4) than K172N’s.
We also analyzed a 222 kb interval surrounding
rTAS2R16 and detected no apparent decay of linkage
tdisequilibrium, as measured by the D’ statistics [24],
swith physical distance (Figure S1). We carried out an
pexact test of linkage disequilibrium for all pairwise sin-
cgle nucleotide polymorphism (SNP) comparisons within
athe region. When we considered all SNPs, 86% of all
npossible pairwise comparisons had significant p-values
4(p % 0.05); 97% of the comparisons were significant if
floci with minor allele frequencies of 0.2 or higher were
tconsidered. We note, however, that extended linkage
tdisequilibrium may result either from positive selection
wor from locally decreased recombination rates [23, 25];
stherefore, extended linkage disequilibrium alone does
Knot provide evidence for selection, although compati-
tble it is with it. Finally, we cannot exclude that a variant
uoutside the sequenced region may be driving the signal
of positive selection at TAS2R16, although we also note
dthat the two closest genes are located at very large
tdistances (around 100 kb) at the limit of the region of
thigh linkage disequilibrium.
aIn addition to K172N, we also investigated the extent
rto which positive selection may have influenced the ge-
mographical distribution of the second nonsynonymous
wvariant (H222R) by using the long-range haplotype test
a(LRH, [26]) (Supplemental Data). The LRH test did not
Kshow evidence of recent positive selection at TAS2R16,and in particular at the H222R site. Because the testetects only recent selection events (roughly within the
ast 10,000 years [26]), this result does not exclude that
elective events may have taken place at this locus in
ore ancient times.
ge of the K172N Allele
e calculated the posterior estimates of the genealogi-
al nodes immediately descendent from K172N on the
oruba sample by using the method of Wilson et al.
27]. Under the model of constant growth, the posterior
5% credible interval for the age of the node is 4,141–
9,571 generations, or 82,824–791,420 yr (assuming 20
ears per generation). Under the coalescent-with-
rowth model, the estimate of the age for the descend-
nt node is 3,887–34,269 generations, corresponding
o 77,751–685,380 yr. Although they have wide credible
ntervals, even the lower range of these estimates
laces the age of the mutation prior to the Neolithic
evolution and prior to the expansion out of Africa un-
er some models [28].
unctional Characterization of the K172N
nd H222R Alleles
172N lies in the second extracellular loop domain of
he TAS2R16 receptor. The K>N exchange at this site
ay affect interaction between the receptor and its li-
ands. The other nonsynonymous site, H222R, lies
ithin the third intracellular loop domain. The H>R ex-
hange at this locus creates a putative protein kinase
site and could influence receptor desensitization. We
nalyzed the function of these two nonsynonymous
ariants by using heterologous expression and calcium
maging. To this end, we transiently transfected plas-
ids containing different permutations of the K172N
nd H222R variants into HEK293 cells containing the
himeric G protein G16-Gust44.
We first tested whether the K172N substitution alters
eceptor function. We challenged cells transfected with
he N172/R222 and the K172/R222 constructs with
even structurally divergent glycosides. The com-
ounds tested are all natural compounds, and they in-
lude salicin (found in willow trees), arbutin (bearberry),
mygdalin (bitter almonds), linamarin (manioc), pru-
asin (almonds), osmaronin epoxide (Rosaceae), and
-glucosyloxymandelonitrile (Berberidaceae) [12]. We
ound that upon stimulation with all agonists, cells con-
aining the TAS2R16 variants responded with a robust
ransient increase of the intracellular-calcium levels,
hereas mock-transfected control cells did not re-
pond (Figure 2A). Notably, at low concentrations, the
172/R222 receptor variant showed a weaker response
o all agonists than the N172/R222 receptor did (Fig-
re 2A).
To test whether the observed functional difference is
ue to altered agonist sensitivity, we next challenged
he K172/R222 and N172/R222 variants with three struc-
urally divergent TAS2R16 agonists (salicin, arbutin, and
mygdalin) and calculated the relative concentration-
esponse curves (Figure 2B). We found that the half-
aximal effective concentrations (EC50) for N172/R222
ere 0.8 ± 0.2 mM for salicin, 5.5 ± 1.9 mM for arbutin,
nd 6.0 ± 1.5 mM for amygdalin. The EC50 values of
172/R222 were right-shifted to higher concentrations,i.e., 2.6 ± 0.9 mM for salicin, 10.8 ± 3.7, mM for arbutin,
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(A) Intracellular-calcium traces of the TAS2R16 constructs N172/R222 and K172/R222, as well as mock-transfected control cells recorded in
the FLIPR experiment upon stimulation with seven structurally divergent compounds, are shown. The scale bar denotes 2000 relative light
units and 1 min.
(B) Concentration-response relations of cells transfected with different TAS2R16 constructs upon stimulation with salicin, arbutin, or amygda-
lin are shown.and 9.9 ± 2.2 mM for amygdalin. Thus, the comparison
of the EC50 values demonstrates a clear functional dif-
ference between receptor variants containing either the
K172 or the N172 allele, with the receptor variant K172/
R222 being about 2-fold less sensitive compared to
N172/R222.
We also tested whether the amino acid substitution
H222R affects the receptor function by challenging the
receptor variants N172/H222 and K172/H222 with sali-
cin, arbutin, and amygdalin (Figure 2B). The EC50 values
of N172/H222 were 1.0 ± 0.2 mM for salicin, 5.4 ± 1.5
mM for arbutin, and 6.1 ± 1.2 mM for amygdalin, and
the EC50 values of K172/H222 were 1.9 ± 0.2 mM for
salicin, 11.5 ± 7.4 mM for arbutin, and 10.1 ± 1.1 mM
for amygdalin. The comparison of the EC50 values of
these variant receptors again revealed a clear func-
tional difference. The receptor variant K172/H222 be-
haved like K172/R222 and showed the same 2-fold shift
in EC50 in comparison to N172/H222, which behaved
like N172/R222 (Figure 2B). These data show that both
receptors containing the K172 allele are less sensitive
to all tested agonists than are the receptors that con-
tain the N172 allele and that this effect is independent
of the amino acid substitution at amino acid position
222.
To examine whether the observed functional differ-
ences were caused by variations in expression rates,
we analyzed the number of cells expressing a given
TAS2R16 variant by immunocytochemistry and West-
ern blot (Supplemental Data). All TAS2R16 variants
showed a similar expression level (Figure S3A–S3C),
and no obvious difference was observed between theTAS2R16 receptors that contained the K172 or the
N172 variant.
Next, we analyzed the cell-surface expression of all
receptor variants by using confocal microscopy. The re-
sults clearly show that all four TAS2R16 variants are
equally well targeted to the cell surface (Figure S3D).
To control whether variations in the transfection rates
could account for the observed differences, we trans-
fected the cells with different dilutions of TAS2R16
N172/R222 (Figure S3E) and determined the EC50 val-
ues in response to salicin. There was no shift in the
EC50 values between undiluted and 1:5 diluted DNA.
Even at a 1:10 dilution, the effects on the EC50 were
very moderate. On the basis of these experiments, we
can conclude that the observed differences between
the TAS2R16 variants are not caused by differences in
the expression rates, cell-surface targeting, or varia-
tions in the transfection protocol.
In summary, we found that the K172 allele alone cre-
ates a 2-fold-less-sensitive receptor, whereas we did
not observe any functional effect of the H222R ex-
change. We have previously demonstrated (B.B. and
W.M.) a strong correlation between in vitro dose-
response measurements for this receptor and response
in humans [12].
Discussion
We detected a clear signature of positive selection at
the bitter-taste receptor gene TAS2R16. This positive-
selection event produced (or was apparent as) an ex-
cess of high-frequency derived alleles at three neigh-
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1262Table 3. K172 Allele Frequency and Current Malaria Risk in African Populations
Population Country N Individuals K172 Frequency (%, G Allele) Malaria Riska
Tunisian Tunisia 17 0 0
Mozabite Algeria 26 9.6 0
Bantu South Africa 28 21 0.2
Amhara Ethiopia 20 7.5 0.4
Bantu Kenya 10 10 0.53
Cameroonian Cameroon 12 33 0.94
Mbuti Pygmies Democratic Republic of Congo 12 17 1
Mandenka Senegal 22 18 1
Biaka Pygmies Central African Republic 31 24 1
Yoruba Nigeria 18 33 1
a Percentage of population living in areas at risk for malaria transmission (endemic risk). Source: Africa Malaria Report 2003 (http://
www.rbm.who.int/amd2003/amr2003/table6.htm); for Tunisia and Algeria, the source is http://www.cdc.gov/travel/regionalmalaria/nafrica.htm.boring loci (V101V, T282T, and K172N). Although any f
sof these three loci could in theory drive the signal of
selection, only the nonsynonymous variant K172N has t
ba clear functional effect and is to date the most likely
target of positive selection. K172N lies in the second i
pextracellular loop domain of the TAS2R16 receptor, a
region implicated in receptor-ligand interaction. We n
bdemonstrated with functional assays based on a heter-
ologous cell system that the N172 allele confers in- c
hcreased sensitivity for a range of seven structurally dif-
ferent glycosides, some with a beneficial effect in c
dhumans (salicin, arbutin) and others toxic (amygdalin,
linamarin, prunasin, osmaronin epoxide and 4-glucosy-
iloxymandelonitrile). The second common nonsynony-
mous site (H222R) did not appear to affect receptor h
bfunction and was not associated with an overall reduc-
tion or increase in fitness. t
lWe estimated that K172N arose between 77,700 and
791,000 yr ago. This places the origin of the mutation w
iwell before the Neolithic revolution and approximately
in the Middle Pleistocene, a stage of human evolution m
mcharacterized by an active hunter-gatherer lifestyle [29].
Given the functional significance of this mutation, it is P
ereasonable to suppose that selective forces acted upon
it as soon as it occurred (although it is not possible for K
mour genetic analyses to demonstrate this with cer-
tainty). The worldwide geographical distribution of the l
tvariant also suggests that the selective sweep occurred
before the human expansion out of Africa 50,000– s
i100,000 yr ago [30], although the differentiation for
K172N suggests that selection has continued after the g
fseparation of major human population groups.
We speculate that N172 may be driving the signal p
of positive selection at TAS2R16 through an increased
protection against cyanogenic plant foods and natural s
mtoxins in general. Because the functional effect of the
N172 variant is similar for all the compounds tested, it d
(is difficult to establish whether a specific compound
underlies the selective sweep. In the absence of paleo- e
cbotanical and archaeological data supporting the role
of a specific food source, we suggest conservatively A
tthat a generalized response to β-glucopyranosides is a
likely cause. K
cThe natural bitter agonists of TAS2R16, β-glucopyra-
nosides [12], are a wide class of natural compounds l
osynthesized by over 2,500 plant and insect species as
a protection against predators [19, 31]. This compound namily also includes various toxic cyanogenic glyco-
ides. Cyanogenic glycosides are toxic as a result of
he release of cyanide ions (CN−) during the enzymatic
reakdown in the intestine; CN− is rapidly absorbed
nto the bloodstream, where it combines with Fe2+ to
roduce cyano-hemoglobin [32]. A single dose of cya-
ide of 1 mg kg−1 body weight is lethal for most verte-
rates [33]. However, chronic exposure to sublethal
oncentrations is tolerated, particularly in conditions of
igh dietary intake of protein [17], where cyanide is
ombined with sulfur-containing amino acids to pro-
uce the less-toxic thiocyanate [34].
One intriguing observation was that the low-sensitiv-
ty ancestral K172 allele was retained at moderately
igh frequencies throughout central Africa, with a distri-
ution (Figure 1B) that appeared remarkably similar to
hose of some malaria-resistance alleles [35]. Chronic
ow-level ingestion of cyanogenic foods has been linked
ith an increased protection against malaria [36]; this
ncrease in protection may take place through various
echanisms including cyanide-induced sickle cell ane-
ia, cyanide-induced oxidative stress, and inhibition of
lasmodium respiratory chain [36–39]. One speculative
xplanation for this distribution could therefore be that
172 has conferred a modest selective advantage in
alaria-infested areas through favoring chronic low-
evel ingestion of cyanogenic glycosides. This hypo-
hetical malaria effect would act antagonistically to the
elective sweep to maintain K172 at high frequencies
n Central Africa. Under this hypothetical scenario, the
lobal pattern of variation at the TAS2R16 gene results
rom a balance between protection against malaria and
rotection against toxins in malaria-free zones.
Testing the above hypothesis would require demon-
trating experimentally a functional role for K172 as a
alaria-resistance allele. To obtain a first qualitative in-
ication, we retrieved a general index of malaria risk
the percentage of population living in areas at risk for
ndemic malaria transmission for each country) and
ompared it to the frequency of the K172 allele in the
frican populations (Table 3). We found that popula-
ions with high malaria risk (>0.7) had higher average
172 allele frequencies (mean 25%, range 17%–33%)
ompared to populations with intermediate or low ma-
aria risk (mean 10%, range 0%–21%), indicating a good
verall correlation between the two variables. We did
ot test this correlation quantitatively because any
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tions in malaria risk since the time of the selective
sweep [35] and historical movements of people [40].
For instance, the South African Bantus are thought to
have reached South Africa from Central Africa at
around 500–1000 BC [40], well after the selective event.
Remarkably, we found that in this population, K172 had
the highest frequency (21%) among populations in
areas of low malaria risk, possibly reflecting the Central
African origin.
In a recent study, Wooding and colleagues suggested
a role for balancing selection in maintaining three func-
tional alleles of TAS2R38 throughout human evolution
[11]. Our study suggests nonneutral evolution for a sec-
ond bitter-taste gene in humans, indicating that posi-
tive as well as balancing selection has contributed to
diversification of TAS2R function. Wang and colleagues
recently suggested overall neutral patterns of evolution
for human TAS2R genes, including TAS2R16 [6]. As the
authors themselves stated, a neutral signal of selection
for the family does not exclude differential selection
acting on specific TAS2R functions. Detecting such se-
lection events may require the application of more-sen-
sitive tests such as Fay and Wu’s statistics.
The proposed selective sweep at K172N may have
consequences for modern human health. β-glucopyra-
nosides are a heterogeneous class of compounds,
some of which are toxic and some of which lower the
risk of cancer and cardiovascular disease [1]. As a re-
sult of their bitter taste, these compounds cause aver-
sion in the consumer and are removed routinely by the
food industry [1]. Aversion to bitter compounds is cur-
rently a main limitation toward increasing the phytonu-
trient content of plant foods as a dietary option for dis-
ease prevention [1]. Although the N172 allele may have
been advantageous in our past through avoidance of
natural toxins, it may now contribute to increasing dis-
ease risk through lowered intake of such beneficial
compounds. The identification of genetic polymor-
phisms affecting receptor function may have relevance
in terms of pharmacological manipulation of bitter-
taste receptors.
Conclusions
Our study provides evidence for positive selection on
the bitter-taste gene TAS2R16. The selective event is
likely to be explained by an increased fine-control of
ingestion of cyanogenic compounds conferred by the
N172 allele. As humans, we display overall reduced
sensory characteristics in comparison to other mam-
mals and primates. However, our study suggests that
preservation of specific sensory functions through pos-
itive selection may have been particularly important, at
least in the earlier stages of human evolution.
Experimental Procedures
Population Samples
DNA for 52 populations of the human diversity panel [20] and the
trios used by the HapMap project were obtained from Dr. Cann
(Fondation Jean Dausset-CEPH). Eight additional populations cov-
ering geographic regions poorly represented in the human diversity
panel (Table S1) were donated to D.B.G. through previous collabo-
rations. Primate DNAs were obtained from the German PrimateCenter (http://www.dpz.gwdg.de/). The following 13 individuals
were excluded from the analysis: HGDP00813, HGDP01233,
HGDP00762, HGDP00111, HGDP01149, HGDP00583, HGDP00650,
HGDP00658, HGDP00657, HGDP00660, HGDP00472, HGDP00452,
and HGDP00457.
Resequencing of the TAS2R16 Gene
The entire coding region of TAS2R16 (876 bp) and 203 bp of 5# and
3# UTR sequence were amplified with the following primers: for-
ward 5#-TAGCAAACCAGCAAGCAAAG-3#; reverse 5#-CGAAGATGG
AAGGGAATGAG-3#. Amplified PCR products were sequenced with
Big Dye Terminator chemistry (Applied Biosystems) with 10 pmoles
forward/reverse primer. Sequence analysis and contig assembly
were performed with Sequencher software (v. 4.0.5, Genecodes).
Sequence traces were scored manually twice, and the genotype
data were checked by random resequencing of 10% of the sam-
ples. The estimated error rate was 0.5%.
Genetic Analyses
Ancestral character states for the TAS2R16 loci were inferred on
the aligned human-primate sequences with the DnaML program
contained in the PHYLIP software package [41]. The maximum-
likelihood character states at each node of an inferred phylogeny
were all determined with likelihood > 95%. Haplotype inference on
the 17 TAS2R16 polymorphic sites was carried out with the expec-
tation-maximization algorithm implemented in ARLEQUIN [42]. Nu-
cleotide-diversity statistics and tests of selection were carried out
with the TAS2R16 sequence data and the DnaSP software (version
4) [43]. Calculation of the among-population differentiation statis-
tics FST was carried out with analysis of molecular variance by hier-
archically grouping the populations in an African and a non-African
sample. FST values were compared to an empirical distribution of
210 genome-wide short insertion/deletion polymorphisms ampli-
fied in the same individuals of the human diversity panel (data
available at http://research.marshfieldclinic.org/genetics/indels/).
Empirical p-values for TAS2R16 loci were calculated as the fraction
of all indels having a FST higher than the observed value. Analysis
of linkage disequilibrium surrounding TAS2R16 was carried out on
genotype data retrieved from the HapMap project (www.hapmap.
org) and spanning 221,998 bp (SNP rs981696 to rs2470984);
TAS2R16 sites were resequenced in our laboratory with the same
trio DNAs. Haplotype inference from trio data and estimation of
linkage disequilibrium were obtained with the TagIT software [44].
Estimation of Allele Age
Estimation of the age of the K172N mutation was carried out with
the BATWING Bayesian MCMC program [27], with models similar
to those described for the analysis of β globin data in that paper.
We used data from the Yoruba sample only, in order to reduce the
problems of recent demographic stratification. Analysis was car-
ried out assuming no current mutation or recombination (thus, all
six polymorphic SNPs in this region are assumed to be UEP [unique
event polymorphisms]), and three recombinant individuals were
dropped from the dataset in order to satisfy this condition. The
root haplotype of the genealogical tree linking the remaining 32
chromosomes was assumed unknown. The per sequence per gen-
eration mutation rate  was assumed to be uniform throughout the
1079 bp sequence. A prior distribution for  was found as follows.
We started with a gamma(3,105) preprior for , based on a genome-
wide substitution rate of 10−8 per 1079 bases. From our compari-
son with chimpanzee sequence, we found two human-chimp fixed
differences in 1079 bp of sequence. Assuming there have been
about 2.5 × 105 generations since the human-chimpanzee split, this
leads to a gamma(3,6 × 105) prior distribution for . For the effec-
tive population size, we assumed gamma(5,2.5 × 10−4) and
gamma(3,2.5 × 10−4) prior distributions under the standard (no
growth) coalescent and coalescent-with-growth models, respec-
tively (the latter is a two-stage model, with no growth in Stage 1
and exponential growth from the initial population size in Stage 2).
The coalescent-with-growth model also requires priors for the per-
generation growth rate [here, set at gamma(2,400)] and the log-
ratio of current to initial effective population size [here, set at
gamma(5,1)]. These priors are fairly broad and are justified further
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mnealogical nodes immediately ancestral and descendent from
K172N) were checked for convergence and mixing via the methods g
vdescribed in Wilson et al. [27].
o
tGeneration of the TAS2R16 Variants and Functional
dExpression Analysis
tN172/H222 (HAP-A) was cloned from genomic DNA into a pcDNA5
WFRT expression vector (Invitrogen) and fused with the first 45 N-ter-
minal amino acids of the somatostatin receptor 3 (sst-tag) to facili-
tate membrane targeting and a C-terminal HSV-epitope to allow
R
immunocytochemical detection as described earlier [12]. The se-
R
quence variants N172/R222 (HAP-B), K172/H222 (HAP-C), and
A
K172/R222 were created by inserting point mutations with the
P
PCR-based Quick Change protocol (Stratagene) according to the
manufacturer’s recommendations. The cloned TAS2R16 gene vari-
Rants were sequenced to verify the mutation and to exclude amplifi-
cation errors during the PCR reaction. All plasmids containing the
receptor variants were transiently transfected into HEK-293T cells
stably expressing the chimeric G protein subunit Gα16gust44 [45] with
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
protocol. After 20–30 hr, cells were loaded for 45 min with the cal-
cium-sensitive dye Fluo4-AM (Molecular Probes, 2 µg/ml in Dul-
becco’s modified Eagle’s medium [DMEM]) and washed three times
in solution C1 (130 mM NaCl, 5 mM KCl, 10 mM Hepes, 2 mM
CaCl2, and 10 mM glucose [pH 7.4]) to remove the excess dye.
Calcium mobilization upon stimulation of the transfected cells with
bitter compounds was monitored with an automated fluorometric
imaging plate reader (FLIPR, Molecular Devices). All ligands were
dissolved in C1 solution. Salicin, arbutin, and amygdalin were ob-
tained from Sigma. All the other ligands were provided by Professor
Adolf Nahrstedt (Münster). The concentration-response curves for
salicin (n = 4), arbutin (n = 3), and amygdalin (n = 2) are the averages
of independent experiments carried out in duplicate on different
days. The obtained calcium signals were corrected for background
fluorescence and the response of mock-transfected cells. Concen-
tration-response curves and EC50 values were calculated in Sigma
Plot by nonlinear regression with the function f(x) = 100/(1+(b/x)^c).
The experiments used to test whether variations in expression
rates caused the observed functional differences among TAS2R16
variants are described in the Supplemental Experimental Pro-
cedures.
Correlation with Malaria Risk
To investigate a correlation between K172 and malaria risk, we ge-
notyped K172 in three additional African samples available in our
laboratory: These included additional central (Cameroon) and
northern (Tunisia) African populations and additional Biaka Pyg-
mies samples (Central African Republic). Malaria-risk data was re- 1
trieved from the Africa Malaria Report 2003 (http://www.rbm.who.
int/amd2003/amr2003/table6.htm); for Algeria and Tunisia, malaria-
risk indexes were set to zero to reflect current risk (http://www.cdc.
gov/travel/regionalmalaria/nafrica.htm) in line with the other pop- 1
ulations. Here, we use current malaria risk as a proxy for the distri-
bution of malaria at the time of the selective sweep, given that the
exact estimates of malaria risk for that time are not known.
1
Supplemental Data
Supplemental Data include three figures, two tables, and Supple-
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